Literature DB >> 31166621

Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.

Michael A Irvine1,2, Margot Kuo2,3, Jane A Buxton2,3, Robert Balshaw4, Michael Otterstatter2, Laura Macdougall2, M-J Milloy5, Aamir Bharmal6, Bonnie Henry7, Mark Tyndall2,3, Daniel Coombs1, Mark Gilbert2,3.   

Abstract

BACKGROUND AND AIMS: The province of British Columbia (BC) Canada has experienced a rapid increase in illicit drug overdoses and deaths during the last 4 years, with a provincial emergency declared in April 2016. These deaths have been driven primarily by the introduction of synthetic opioids into the illicit opioid supply. This study aimed to measure the combined impact of large-scale opioid overdose interventions implemented in BC between April 2016 and December 2017 on the number of deaths averted.
DESIGN: We expanded on the mathematical modelling methodology of our previous study to construct a Bayesian hierarchical latent Markov process model to estimate monthly overdose and overdose-death risk, along with the impact of interventions. SETTING AND CASES: Overdose events and overdose-related deaths in BC from January 2012 to December 2017.
INTERVENTIONS: The interventions considered were take-home naloxone kits, overdose prevention/supervised consumption sites and opioid agonist therapy MEASUREMENTS: Counterfactual simulations were performed with the fitted model to estimate the number of death events averted for each intervention and in combination.
FINDINGS: Between April 2016 and December 2017, BC observed 2177 overdose deaths (77% fentanyl-detected). During the same period, an estimated 3030 (2900-3240) death events were averted by all interventions combined. In isolation, 1580 (1480-1740) were averted by take-home naloxone, 230 (160-350) by overdose prevention services and 590 (510-720) were averted by opioid agonist therapy.
CONCLUSIONS: A combined intervention approach has been effective in averting overdose deaths during British Columbia's opioid overdose crisis in the period since declaration of a public health emergency (April 2016-December 2017). However, the absolute numbers of overdose deaths have not changed.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  Bayesian modelling; opioid agonist therapy; opioid overdose crisis; overdose prevention sites; public health intervention; take-home naloxone

Year:  2019        PMID: 31166621      PMCID: PMC6684858          DOI: 10.1111/add.14664

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  30 in total

Review 1.  Methods in health service research. An introduction to bayesian methods in health technology assessment.

Authors:  D J Spiegelhalter; J P Myles; D R Jones; K R Abrams
Journal:  BMJ       Date:  1999-08-21

2.  Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.

Authors:  Mark W Tyndall; Thomas Kerr; Ruth Zhang; Evelyn King; Julio G Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2005-12-13       Impact factor: 4.492

3.  Uncertainty in predictions of disease spread and public health responses to bioterrorism and emerging diseases.

Authors:  Bret D Elderd; Vanja M Dukic; Greg Dwyer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

4.  Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Authors:  Brandon D L Marshall; M-J Milloy; Evan Wood; Julio S G Montaner; Thomas Kerr
Journal:  Lancet       Date:  2011-04-15       Impact factor: 79.321

5.  Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006.

Authors:  Amy S B Bohnert; Marta R Prescott; David Vlahov; Kenneth J Tardiff; Sandro Galea
Journal:  Addiction       Date:  2010-03-02       Impact factor: 6.526

6.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.

Authors:  Phillip O Coffin; Sean D Sullivan
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

7.  Structural and parameter uncertainty in Bayesian cost-effectiveness models.

Authors:  Christopher H Jackson; Linda D Sharples; Simon G Thompson
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2010-03       Impact factor: 1.864

Review 8.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  R P Mattick; J Kimber; C Breen; M Davoli
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

9.  Modelling the hepatitis C virus epidemic in Australia.

Authors:  Karina Razali; Hla Hla Thein; Jane Bell; Mark Cooper-Stanbury; Kate Dolan; Greg Dore; Jacob George; John Kaldor; Maria Karvelas; Jiong Li; Lisa Maher; Sharyn McGregor; Margaret Hellard; Fiona Poeder; Julianne Quaine; Kim Stewart; Helen Tyrrell; Martin Weltman; Owen Westcott; Alex Wodak; Matthew Law
Journal:  Drug Alcohol Depend       Date:  2007-07-31       Impact factor: 4.492

10.  Modelling and calibration of the hepatitis C epidemic in Australia.

Authors:  K Razali; J Amin; G J Dore; M G Law
Journal:  Stat Methods Med Res       Date:  2008-11-26       Impact factor: 3.021

View more
  50 in total

Review 1.  Maternity Care for Pregnant Women with Opioid Use Disorder: A Review.

Authors:  Abigail H Rizk; Sara E Simonsen; Leissa Roberts; Lisa Taylor-Swanson; Jennifer Berkowicz Lemoine; Marcela Smid
Journal:  J Midwifery Womens Health       Date:  2019-08-12       Impact factor: 2.388

Review 2.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

3.  Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.

Authors:  Ryan McNeil; Taylor Fleming; Samara Mayer; Allison Barker; Manal Mansoor; Alex Betsos; Tamar Austin; Sylvia Parusel; Andrew Ivsins; Jade Boyd
Journal:  Am J Public Health       Date:  2022-03-09       Impact factor: 9.308

4.  Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Miranda Compton; Thomas Kerr
Journal:  Addiction       Date:  2021-12-02       Impact factor: 6.526

5.  "Bed Bugs and Beyond": An ethnographic analysis of North America's first women-only supervised drug consumption site.

Authors:  Jade Boyd; Jennifer Lavalley; Sandra Czechaczek; Samara Mayer; Thomas Kerr; Lisa Maher; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-04-02

6.  Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Jade Boyd; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2020-03-19

7.  Assisted injection within supervised injection services: Uptake and client characteristics among people who require help injecting in a Canadian setting.

Authors:  Mary Clare Kennedy; M-J Milloy; Kanna Hayashi; Elizabeth Holliday; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2020-10-08

8.  Examining the gender composition of drug injecting initiation events: A mixed methods investigation of three North American contexts.

Authors:  Meyers Sa; Rafful C; Mittal Ml; Smith Lr; Tirado-Muñoz J; Jain S; Sun X; Garfein Rs; Strathdee Sa; DeBeck K; Hayashi K; McNeil R; Milloy Mj; Olding M; Guise A; Werb D; Scheim Ai
Journal:  Int J Drug Policy       Date:  2020-12-11

9.  "And we just have to keep going": Task shifting and the production of burnout among overdose response workers with lived experience.

Authors:  Michelle Olding; Jade Boyd; Thomas Kerr; Ryan McNeil
Journal:  Soc Sci Med       Date:  2021-01-05       Impact factor: 4.634

10.  The implementation and role of a staff naloxone program for non-profit community-based sites in British Columbia: A descriptive study.

Authors:  Sierra Williams; Tanis King; Kristi Papamihali; Jane A Buxton
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.